[artículo] 
inThe American Journal of Psychiatry > Año 2025 - Vol. 182 - No.3 (Marzo) . - PP. 259–275

Título :	Esketamine treatment for depression in adults: a prisma systematic review and meta-analysis
Tipo de documento:	texto impreso
Autores:	Konstantinos N. Fountoulakis, Autor ; Athanasios Saitis, Autor ; Alan F. Schatzberg, Autor
Fecha de publicación:	2025
Artículo en la página:	PP. 259–275
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastornos depresivos, Ketamina - Esketamina, Metaanálisis, Tendencia suicida, Depresión resistente al tratamiento.
Resumen:	Intranasal esketamine has been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior. The authors conducted a systematic review and meta-analysis of the available data on its efficacy against depression and suicidality as well as its side effects.
Link:	./index.php?lvl=notice_display&id=31589

[artículo] Esketamine treatment for depression in adults: a prisma systematic review and meta-analysis [texto impreso] / Konstantinos N. Fountoulakis, Autor ; Athanasios Saitis, Autor ; Alan F. Schatzberg, Autor . - 2025 . - PP. 259–275.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2025 - Vol. 182 - No.3 (Marzo) . - PP. 259–275

Palabras clave:	Trastornos depresivos, Ketamina - Esketamina, Metaanálisis, Tendencia suicida, Depresión resistente al tratamiento.
Resumen:	Intranasal esketamine has been approved as an adjunctive therapy for treatment-resistant major depressive disorder with acute suicidal ideation and behavior. The authors conducted a systematic review and meta-analysis of the available data on its efficacy against depression and suicidality as well as its side effects.
Link:	./index.php?lvl=notice_display&id=31589